Pharmafile Logo
Pharmafocus logo
Advanced Search

Contract research sector: news in brief

July 13, 2009
Research and Development Veeda

Pharmafocus presents a round-up of developments in the contract research sector, including Icon's acquisition of biomarker specialist Veeda, layoffs at …

News

AstraZeneca’s AZD3480 progresses in ADHD

July 11, 2009
Sales and Marketing ADHD, Alzheimer's, Alzheimer's ADHD, AstraZeneca

 AstraZeneca is to progress its AZD3480 (TC-1734) for attention deficit/hyperactivity disorder (ADHD) and has agreed to make a $10 million …

News

Adventis Health launches brand competition

July 10, 2009
Medical Communications Adventis

Adventis Health has celebrated its official launch as a fully integrated healthcare communications agency. To mark this milestone, the company …

News

Pfizer to set up new lab in Ireland

July 10, 2009
Manufacturing and Production Europe, Ireland, Pfizer

Pfizer has earmarked an 11 million euro investment for a new kilo-scale R&D facility at its manufacturing facility in Ringaskiddy, …

News

Biopharma company contributes to GSK’s ‘patent pool’

July 10, 2009
Research and Development Orphan

Biopharma company Alnylam Pharmaceuticals is to put some of its intellectual property at the disposal of researchers into neglected tropical …

News

WHO gives Cervarix green light for use in developing nations

July 10, 2009
Research and Development, Sales and Marketing Cervarix, vaccines

News

NICE to reconsider GSK’s Tyverb

July 9, 2009
Research and Development, Sales and Marketing GSK, NICE, Tyverb

NICE is to reconsider Tyverb under its new lenient approach for end-of-life drugs, after GSK appealed its previous rejection of …

News

Victoza launched in UK

July 9, 2009
Sales and Marketing Victoza, diabetes

Novo Nordisk this week launched its much-anticipated type II diabetes treatment Victoza in the UK. Victoza (liraglutide) is the first …

News

New clients for Cegedim Dendrite

July 9, 2009
Medical Communications Cegedim

Cegedim Dendrite, a leading provider of CRM software and healthcare data to the pharma industry, has announced significant growth over …

News

Writing on the wall for ‘pay to delay’ generics deals

July 9, 2009
Research and Development, Sales and Marketing FDA, US, generics

Deals allowing US pharma companies to pay generics competitors to delay the launch of rival products should be ended, according …

News

Genzyme’s woes are a boost for Shire and Protalix

July 9, 2009
Research and Development, Sales and Marketing FDA, Genzyme, US

The contamination problems at a plant used by Genzyme to manufacture a drug for Gaucher disease have prompted the US …

News

Europe launches pharma competition crackdown

July 8, 2009
Research and Development Europe, generics

The European Union's competition watchdog has declared a crackdown on pharma industry competition, promising scrutiny of deals which it says …

News
Eisai's new European HQ in Hatfield, Hertfordshire

Eisai opens new European HQ in the UK

July 8, 2009
Manufacturing and Production, Research and Development, Sales and Marketing Eisai, Europe, HQ

Eisai has officially opened its new European headquarters in the UK, its biggest-ever single capital investment that will bring teams …

Feature
UCB's new biologics research centre in Slough

UCB opens new UK biologics research centre

July 8, 2009
Research and Development UCB

 UCB has officially opened its new biologics research centre in the UK, representing an investment of £25 million for the …

News

GMP violations at Indian CMO hit UK generics makers

July 8, 2009
Manufacturing and Production Asia, India

Eight manufacturers of generic medicines in the UK have been forced to withdraw batches of product from the market because …

News

Sanofi moves to quell Lantus safety concerns

July 7, 2009
Research and Development, Sales and Marketing Lantis, Sanofi-Aventis, diabetes

Sanofi-Aventis has rejected claims of a possible connection between its diabetes treatment Lantus and cancer. The possible link was reported …

News

Depression warnings for Chantix and Zyban

July 7, 2009
Research and Development, Sales and Marketing Chantix, FDA, US, drug safety

Pfizer and GSK's smoking cessations drugs will have to carry strong warnings of depression and other mental health adverse events …

News

PM Soc’s Digital Media Awards to highlight pioneering work

July 7, 2009
Sales and Marketing digi, pm society

UK pharma companies and agencies are being invited to submit entries to the industry's first-ever digital media awards, which aim …

News
VasellaWEB

Vasella: on leadership

July 7, 2009
Sales and Marketing Novartis, Vasella, leadership, management

Novartis’ chief executive and chairman talks to McKinsey about his personal approach to management and leadership, and examines subjects including …

Feature

Pharmaceutical manufacturing: news in brief

July 6, 2009
Manufacturing and Production Genzyme, Quotient

Pharmafocus presents a round-up of developments in manufacturing, including facility updates from Genzyme, Caraco, MSD, Rottapharm and Almac Pharma Services, …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026